$617 Million is the total value of Antara Capital LP's 43 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 143.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | Match Group Inccall | $130,429,000 | – | 1,975,000 | +100.0% | 21.14% | – | |
Buy | Tiffany & Coput | $66,252,000 | +6.6% | 511,600 | +10.0% | 10.74% | -14.7% | |
New | IAC/interactivecorpput | $56,547,000 | – | 315,500 | +100.0% | 9.17% | – | |
New | Match Group Incput | $39,723,000 | – | 601,500 | +100.0% | 6.44% | – | |
Buy | Eldorado Resorts Incput | $27,756,000 | +365.4% | 1,927,500 | +1827.5% | 4.50% | +272.4% | |
Buy | Tilray Incnote 5.000% 10/0 | $26,961,000 | +20.8% | 81,700,000 | +95.9% | 4.37% | -3.3% | |
Buy | Tilray Incput | $24,957,000 | +74.0% | 3,627,400 | +333.2% | 4.04% | +39.2% | |
IAC | Buy | IAC/interactivecorp | $23,350,000 | +368.7% | 130,280 | +551.4% | 3.78% | +275.1% |
Buy | Innoviva Inccall | $22,130,000 | +50.7% | 1,881,800 | +81.4% | 3.59% | +20.5% | |
TIF | New | Tiffany & Co | $19,425,000 | – | 150,000 | +100.0% | 3.15% | – |
Buy | Clovis Oncology Incnote 1.250% 5/0 | $18,447,000 | +30.9% | 28,434,000 | +29.6% | 2.99% | +4.7% | |
New | Russell 2000 Total Return Indexput | $17,169,000 | – | 150,000 | +100.0% | 2.78% | – | |
Buy | UniQure NVcall | $15,815,000 | +66.6% | 333,300 | +151.5% | 2.56% | +33.2% | |
New | IBoxx USD Liquid High Yield Indexput | $15,545,000 | – | 201,700 | +100.0% | 2.52% | – | |
Buy | Clovis Oncology Inccall | $13,764,000 | +120.0% | 2,164,100 | +260.7% | 2.23% | +76.1% | |
New | Innoviva Incput | $11,760,000 | – | 1,000,000 | +100.0% | 1.91% | – | |
Buy | Aurinia Pharmaceuticals Inccall | $9,918,000 | -5.9% | 683,500 | +31.4% | 1.61% | -24.7% | |
Buy | IAC/interactivecorpcall | $9,804,000 | +31.2% | 54,700 | +82.3% | 1.59% | +5.0% | |
New | UniQure NVput | $7,246,000 | – | 152,700 | +100.0% | 1.18% | – | |
Buy | Tilray Inccall | $7,224,000 | -17.3% | 1,050,000 | +105.9% | 1.17% | -33.8% | |
Buy | Eldorado Resorts Inccall | $7,200,000 | -71.6% | 500,000 | +17.6% | 1.17% | -77.3% | |
New | Caesars Entertainment Corpcall | $6,794,000 | – | 1,005,000 | +100.0% | 1.10% | – | |
New | Qiagen NVput | $6,240,000 | – | 150,000 | +100.0% | 1.01% | – | |
New | Iovance Biotherapeutics Inccall | $5,987,000 | – | 200,000 | +100.0% | 0.97% | – | |
New | Deciphera Pharmaceuticals Inccall | $4,529,000 | – | 110,000 | +100.0% | 0.73% | – | |
Buy | Aurinia Pharmaceuticals Incput | $4,353,000 | +43.2% | 300,000 | +100.0% | 0.71% | +14.6% | |
New | Amarin Corp PLCcall | $2,932,000 | – | 733,100 | +100.0% | 0.48% | – | |
IHRT | New | IHeartMedia Inc | $2,608,000 | – | 356,800 | +100.0% | 0.42% | – |
TUFN | New | Tufin Software Technologies Ltd | $1,624,000 | – | 185,000 | +100.0% | 0.26% | – |
Buy | Intelsat SAcall | $1,530,000 | -70.2% | 1,000,000 | +37.0% | 0.25% | -76.2% | |
CZR | New | Caesars Entertainment Corp | $1,318,000 | – | 195,000 | +100.0% | 0.21% | – |
BNED | Buy | Barnes & Noble Education Inc | $1,099,000 | -22.6% | 807,755 | +143.0% | 0.18% | -38.2% |
CLNY | New | Colony Capital Inc | $519,000 | – | 296,617 | +100.0% | 0.08% | – |
New | Barnes & Noble Education Inccall | $340,000 | – | 250,000 | +100.0% | 0.06% | – | |
XELA | New | Exela Technologies Inc | $132,000 | – | 644,584 | +100.0% | 0.02% | – |
TEN | New | Tenneco Inc | $128,000 | – | 35,651 | +100.0% | 0.02% | – |
OACWS | New | Oaktree Acquisition Corpw exp 99/99/999 | $88,000 | – | 84,333 | +100.0% | 0.01% | – |
VER | New | Vereit Inc | $49,000 | – | 10,000 | +100.0% | 0.01% | – |
AUPH | New | Aurinia Pharmaceuticals Inc | $4,000 | – | 300 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CLOVIS ONCOLOGY INC | 14 | Q3 2022 | 4.8% |
Barnes & Noble Education Inc | 13 | Q4 2022 | 0.8% |
INNOVIZ TECHNOLOGIES LTD | 10 | Q3 2023 | 4.0% |
INNOVIZ TECHNOLOGIES LTD | 10 | Q3 2023 | 0.7% |
KERNEL GROUP HOLDINGS INC | 10 | Q3 2023 | 0.0% |
MAGNUM OPUS ACQUISITION LTD | 10 | Q3 2023 | 0.0% |
BLUERIVER ACQUISITION CORP | 10 | Q2 2023 | 0.0% |
PROSPECTOR CAPITAL CORP | 10 | Q3 2023 | 0.0% |
CANTALOUPE INC | 9 | Q2 2023 | 1.7% |
ANZU SPECIAL ACQUISITIN CORP | 9 | Q2 2023 | 0.0% |
View Antara Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AMC ENTERTAINMENT HOLDINGS, INC.Sold out | August 31, 2023 | 0 | 0.0% |
Arrival | August 08, 2023 | 3,217,275 | 14.9% |
CANTALOUPE, INC. | March 10, 2023 | 8,242,506 | 11.4% |
ALPHA HEALTHCARE ACQUISITION CORP III | February 14, 2023 | 785,000 | 5.1% |
EVO Transportation & Energy Services, Inc. | December 28, 2022 | 363,731,470 | 95.0% |
Athena Technology Acquisition Corp. II | March 03, 2022 | 1,600,000 | 6.3% |
Jackson Acquisition Co | March 03, 2022 | 1,500,000 | 7.5% |
Revelstone Capital Acquisition Corp. | March 03, 2022 | 1,125,000 | 7.5% |
Fintech Acquisition Corp V | February 24, 2022 | 2,279,136 | 8.9% |
CANTALOUPE, INC. | February 16, 2022 | 2,419,472 | 3.4% |
View Antara Capital LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
4 | 2024-05-13 |
SC 13G/A | 2024-05-13 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Antara Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.